Gradientech
Edit

Gradientech

http://gradientech.se/
Last activity: 06.08.2026
Active
Categories: BioTechDiagnosticsHealthcareMedTechSaaS
Gradientech is developing the microfluidic platform of tomorrow, today. Our revolutionising in vitro diagnostic system, QuickMIC®, is designed to strengthen labs by providing reliable results, at outstanding speed. Visit to experience how.
Followers
602
Website visits
7.1K /mo.
Mentions
114
Location: Sweden
Employees: 11-50
Founded date: 2009

Investors 2

Mentions in press and media 114

DateTitleDescription
06.08.2026Gradientech carries out a rights issue of approximately SEK 55 millionGradientech carries out a rights issue of approximately SEK 55 million Thu, Aug 06, 2026 14:29 CET Report this content The Board of Directors of Gradientech AB (publ) (“Gradientech” or “the Company”) decided on 6 August 2026 to carry out a ...
04.08.2026Gradientech appoints Sumi Thaker as Chief Executive Officer to lead its next phase of commercial growthGradientech appoints Sumi Thaker as Chief Executive Officer to lead its next phase of commercial growth Tue, Aug 04, 2026 17:24 CET Report this content Gradientech, a diagnostics company pioneering ultra-rapid antibiotic susceptibility test...
13.05.2026Gradientech: Interim report January–March 2026Gradientech: Interim report January–March 2026 Wed, May 13, 2026 08:00 CET Report this content Gradientech AB (publ) interim report for Q1 2026 is now available on the company's website www.gradientech.se. First quarter 2026 Net sales amoun...
06.05.2026Multicenter study shows QuickMIC delivers actionable AST results within the same shiftMulticenter study shows QuickMIC delivers actionable AST results within the same shift Wed, May 06, 2026 13:23 CET Report this content Gradientech today announces the publication of a major European multicenter study demonstrating that its ...
23.04.2026Gradientech receives US patent allowance for its QuickMIC testGradientech receives US patent allowance for its QuickMIC test Thu, Apr 23, 2026 10:11 CET Report this content Gradientech today announces having received a Notice of Allowance in the United States for its single-use microfluidic test, a ke...
15.04.2026Gradientech publishes Annual Report for 2025Gradientech publishes Annual Report for 2025 Wed, Apr 15, 2026 08:00 CET Report this content Gradientech AB's Annual Report for 2025 has been published and is now available on the company's website. The Annual Report for 2025 is attached to...
15.04.2026Gradientech Reports Promising Interim Performance Data Including Cefiderocol for Expanded QuickMIC Gram-Negative PanelGradientech Reports Promising Interim Performance Data Including Cefiderocol for Expanded QuickMIC Gram-Negative Panel Wed, Apr 15, 2026 11:56 CET Report this content Gradientech today announces encouraging preliminary results from its ongo...
31.03.2026Gradientech Strengthens Momentum at ESCMID Global 2026 with Multiple Abstracts and Exhibition PresenceGradientech Strengthens Momentum at ESCMID Global 2026 with Multiple Abstracts and Exhibition Presence Tue, Mar 31, 2026 08:00 CET Report this content Gradientech today announces a strong presence at ESCMID Global 2026, combining multiple a...
26.03.2026Gradientech announces outcome of rights issueGradientech announces outcome of rights issue Thu, Mar 26, 2026 13:28 CET Report this content The diagnostics company Gradientech AB (publ) ("Gradientech" or the "Company") today announces the outcome of the new issue of...
04.03.2026Gradientech publishes prospectusGradientech publishes prospectus Wed, Mar 04, 2026 15:50 CET Report this content The Board of Directors of Gradientech AB (publ) (“Gradientech” or “the Company”) decided on 26 February 2026 to carry out a new issue of shares with preferenti...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In